Clinical Trial Update: The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on combining immunotherapy with stereotactic ablative radiotherapy for MSS oligometastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN